Mochi Health is a telehealth company founded in 2022 that specializes in obesity medicine. It provides individualized weight loss programs through a platform connecting patients with board-certified physicians and registered dietitians. Treatment plans are evidence-based and include access to GLP-1 medications such as Semaglutide and Tirzepatide.
The company's platform has served over 100,000 patients nationwide, with a collective weight loss of more than 5 million pounds. Members achieve an average weight loss of 10% within six months, and the typical loss is 36 pounds in the first year. Retention is high, with five out of six members continuing beyond their initial month.
Mochi Health's approach frames obesity as a complex health issue, offering compassionate care with transparent pricing and 24/7 support. It aims to remove traditional barriers to medication access and healthcare services.
